Daily non-political popular news in brief.

ESRF lightsource helps tailoring new treatments against asthma

Researchers from Sweden and France have deciphered the crystal structure of a human membrane protein which has a major influence on the development of asthma. They used the ESRF macromolecular crystallography experimental stations (beamlines) to determine the structure of this pharmaceutically important protein, only the third human membrane protein to be solved. The scientists now believe that their work will enable the development of new and better therapeutic drugs targeting inflammation of the respiratory tract.

Read more »

Keywords: esrf, lightsource, tailoring, treatments, asthma, treatment

« Previous | Next »

Similar news on "ESRF lightsource helps tailoring new treatments against asthma":

1. Inhaled steroids best treatment for children with asthma
   01-23-2007 · EurekAlert!
   Although several medications are available to help children maintain asthma control, clinical trials directly comparing them have not been conducted. In fact, current recommendations in national and international asthma guidelines are based either on studies of single treatments compared to a placebo in children or on comparison studies in adults.
   Similar news · Read more »
   
2. Study indicates different treatment may be needed for infection-related breathing problems
   01-31-2007 · EurekAlert!
   New research suggests that different treatments may be needed for chronic asthma, depending on whether it results from allergies or lung infections.
   Similar news · Read more »
   
3. Study indicates different treatment may be needed for infection-related breathing problems
   01-31-2007 · UT Southwestern Medical Center
   New research suggests that different treatments may be needed for chronic asthma, depending on whether it results from allergies or lung infections.
   Similar news · Read more »
   
4. Model to study age-related macular degeneration could pave way for better treatment
   10-09-2007 · EurekAlert!
   Researchers at the University of Pennsylvania School of Medicine have created the first animal model of age-related macular degeneration caused by a mutation known to produce disease in people, an important first step in developing treatments.
   Similar news · Read more »
   
5. New research demonstrates potential diagnosis, treatment benefits
   01-10-2008 · EurekAlert!
   Studies published in the Jan. 10 edition of the New England Journal of Medicine are providing clues into the treatment and diagnosis of LAM, or lymphangioleiomyomatosis, a progressive and deadly lung disease that affects women in their childbearing years. There currently are no treatments for LAM and scientists estimate as many as 250,000 women may be going misdiagnosed or undiagnosed.
   Similar news · Read more »
   
6. Researchers challenge previous findings regarding widely used asthma treatment
   01-10-2008 · EurekAlert!
   A new study published recently in The Lancet reveals that one of the most commonly used asthma medicines -- long-acting beta-agonists -- may not be associated with adverse events in people based on their genotype, as previous studies had shown. The study analyzed the effects of long-acting beta-agonist therapy, used in combination with inhaled corticosteroids, in asthmatics who have a specific beta-2 adrenergic receptor genotype.
   Similar news · Read more »
   
7. Carefully monitored treatment can help two-thirds of those who suffer from depression
   11-01-2006 · EurekAlert!
   More than two-thirds of people who suffer from major depression can become symptom-free if they are willing to work with their doctors and try various treatments to determine which work best for them, which may involve taking different antidepressants or adding cognitive therapy to the mix.
   Similar news · Read more »
   
8. New study shows Actonel almost halves the risk of hip fractures compared to alendronate
   11-17-2006 · EurekAlert!
   Data published today from a retrospective study of over 33,000 postmenopausal women showed that among patients newly prescribed one of the two most popular osteoporosis treatments, patients taking Actonel® (risedronate sodium) were approximately half as likely to sustain a hip fracture as those taking alendronate in the first year of treatment. These results were published today in the peer-reviewed journal Osteoporosis International.1
   Similar news · Read more »
   
9. Women well-informed about breast cancer, yet lacking knowledge about current treatments
   06-12-2007 · EurekAlert!
   According to a new GfK Roper Public Affairs survey sponsored by CancerCare, a national nonprofit cancer support organization, while 76 percent of women surveyed said they know at least a fair amount about breast cancer, many remain unaware of the important recent progress made in treatment
   Similar news · Read more »
   
10. Alcohol survey reveals 'lost decade' between ages of disorder onset and treatment
    07-02-2007 · EurekAlert!
    The summary article from NIAAA's 2001-2002 National Epidemiologic Survey on Alcohol and Related Conditions presents essential information for treatment services policy and planning, including alcohol use disorder (AUD) and comorbid psychiatric disorder prevalence; age of onset and disease course; and treatment status by treatment type. The researchers found that age of greatest risk for AUDs is 19 years, treatment rates are lower than a decade earlier, and -- especially dismaying given the availability of proven treatments.
    Similar news · Read more »